Bob Hugin is a civic and business leader with significant interests in life sciences, technology, hospitality, and real estate in New Jersey. He retired in 2018, as Chairman and Chief Executive Officer of Celgene Corporation, a global innovative biopharmaceutical company focused on the discovery, development, and commercialization of transformational therapies for unmet medical needs. He is past Chairman of the Boards of the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Healthcare Institute of New Jersey (HINJ). Prior to joining Celgene, Mr. Hugin was a Managing Director with J.P. Morgan & Co. Inc.

Bob serves as a director of Chubb Limited, Biohaven Pharmaceuticals and the Parker Institute for Cancer Immunotherapy. He is a charter trustee of Princeton University, a founding member of the Garden State Initiative, a nonpartisan economic focused think tank. He is a longstanding member of the Board of Trustees of Family Promise, a national non-profit network assisting homeless families. He is a member and past chair of the Board of the Darden School Foundation, University of Virginia. Mr. Hugin chaired the New Jersey Republican State Committee from 2021 to 2025.

Mr. Hugin received an AB degree from Princeton University in 1976 and an MBA from the University of Virginia in 1985 and served as a United States Marine Corps infantry officer during the intervening period. Bob and his wife Kathy have three children and live in Summit, NJ.